(Q40744054)

23 September 2017

0 references

Oral enteric vaccines--clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836466

6 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836466

6 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

6 December 2022

author name string

C. A. Gilligan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836466

6 December 2022

A. Li Wan Po

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836466

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1836466

6 December 2022

publication date

1 October 1991

1 reference

full work available at URL

23 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2710.1991.tb00321.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.1991.tb00321.x/fullpdf

6 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Journal of Clinical Pharmacy and Therapeutics

6 December 2022

published in

1 reference

23 September 2017

16

1 reference

23 September 2017

5

1 reference

23 September 2017

309-335

1 reference

Measles, mumps, rubella, and varicella

23 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Modern vaccines. Mycobacterial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

The intestinal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

The common mucosal immune system and current strategies for induction of immune responses in external secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Modern vaccines. Enteric infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Actions of cholera toxin and the prevention and treatment of cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Field trial of oral cholera vaccines in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Development of improved cholera vaccine based on subunit toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Circulating cholera antitoxin memory cells in the blood one year after oral cholera vaccination in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Five-year immunologic memory in Swedish volunteers after oral cholera vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

A seven-year field trial of two typhoid vaccines in Guyana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Salmonella-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Genetic characteristics of the Salmonella typhi strain Ty21a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Avirulent Salmonella typhimurium delta cya delta crp oral vaccine strains expressing a streptococcal colonization and virulence antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Auxotrophic Salmonella typhi as live vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Immunisation of volunteers with a synthetic peptide vaccine for enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Development of an auxotrophic oral live Shigella flexneri vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. II. Preliminary results of vaccination of adult volunteers and children aged 2-17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00321.X

21 January 2018

Microbiological sciences

2

4

324

Kaufmann S.

1987

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Pneumococcal vaccine: an emerging consensus

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Review of recent pneumococcal infections with attention to vaccine and nonvaccine serotypes.

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Recent progress in immune responses in gut.

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Endemic cholera in rural Bangladesh, 1966-1980.

6 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection

6 December 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Duration of infection-derived immunity to cholera

6 December 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

6 December 2022

35

111

395

Fubara E.S.

1973

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Antitoxic Immunity in Experimental Canine Cholera

6 December 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.

6 December 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Intestinal antibody responses after immunisation with cholera B subunit

6 December 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid

6 December 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Field Trial of Oral Cholera Vaccines in Bangladesh: Results of One Year of Follow-Up

6 December 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine

6 December 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Bangladesh Medical Research Council Bulletin

6 December 2022

49

8

31

Adihya S.

1982

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.

6 December 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease

6 December 2022

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine

6 December 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

IgG and IgA Subclass Distribution of Antitoxin Antibody Responses after Oral Cholera Vaccination or Cholera Disease

6 December 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil

6 December 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans

6 December 2022

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

A Recombinant Live Oral Cholera Vaccine

6 December 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults

6 December 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Summary of an international workshop on typhoid fever

6 December 2022

68

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

American Journal of Hygiene

6 December 2022

69

79

196

Ashcroft M.T.

1964

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Immunity in Experimental Salmonellosis III. Comparative Immunization with Viable and Heat-Inactivated Cells of Salmonella typhimurium

6 December 2022

80

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

6 December 2022

83

133

988

Tagliabue A.

1984

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Clinical and Experimental Immunology

6 December 2022

84

62

242

Tagliabue A.

1985

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

6 December 2022

85

135

4178

Tagliabue A.

1985

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

6 December 2022

86

137

1504

Tagliabue A.

1986

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans

6 December 2022

98

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2.

6 December 2022

106

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain

6 December 2022

110

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Perspective on the development and deployment of rotavirus vaccines.

6 December 2022

118

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers

6 December 2022

121

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants

6 December 2022

122

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

Size and structure of the cholera toxin molecule and its subunits

6 December 2022

124

1 reference

https://api.crossref.org/works/10.1111/J.1365-2710.1991.TB00321.X

6 December 2022

Identifiers

1 reference

23 September 2017

1 reference